Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Susan Adams

Showing results (91-100 of 97) with videos related to

Pageof 10
Sort By:
You have reached the last page of results.This site can display upto 97 results.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Bone-targeted 2,6,9-trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseasesYihan Wang, Chester A Metcalf, William C Shakespeare, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Bone-targeted Src kinase inhibitors: novel pyrrolo- and pyrazolopyrimidine analoguesRaji Sundaramoorthi, William C Shakespeare, Terence P Keenan, et al.
ANZ Journal of Surgery|October 3, 2025
Same-Day Discharge for Paediatric Uncomplicated Appendicitis in AustraliaKyla A Clasie, Stephanie G Ng, Susan Adams, et al.
Annals of Surgery|February 25, 2021
International Core Outcome Set for Acute Simple Appendicitis in Children: Results of a Systematic Review, Delphi Study, and Focus Croups With Young PeopleMax Knaapen, Nigel J Hall, Darcy Moulin, et al.
Chemical Biology & Drug Design|January 9, 2008
SAR of carbon-linked, 2-substituted purines: synthesis and characterization of AP23451 as a novel bone-targeted inhibitor of Src tyrosine kinase with in vivo anti-resorptive activityWilliam C Shakespeare, Yihan Wang, Regine Bohacek, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agentsChi B Vu, George P Luke, Noriyuki Kawahata, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Pageof 10

Showing results (91-100 of 97) with videos related to

Sort By:
Pageof 10
You have reached the last page of results.This site can display upto 97 results.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Bone-targeted 2,6,9-trisubstituted purines: novel inhibitors of Src tyrosine kinase for the treatment of bone diseasesYihan Wang, Chester A Metcalf, William C Shakespeare, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Bone-targeted Src kinase inhibitors: novel pyrrolo- and pyrazolopyrimidine analoguesRaji Sundaramoorthi, William C Shakespeare, Terence P Keenan, et al.
ANZ Journal of Surgery|October 3, 2025
Same-Day Discharge for Paediatric Uncomplicated Appendicitis in AustraliaKyla A Clasie, Stephanie G Ng, Susan Adams, et al.
Annals of Surgery|February 25, 2021
International Core Outcome Set for Acute Simple Appendicitis in Children: Results of a Systematic Review, Delphi Study, and Focus Croups With Young PeopleMax Knaapen, Nigel J Hall, Darcy Moulin, et al.
Chemical Biology & Drug Design|January 9, 2008
SAR of carbon-linked, 2-substituted purines: synthesis and characterization of AP23451 as a novel bone-targeted inhibitor of Src tyrosine kinase with in vivo anti-resorptive activityWilliam C Shakespeare, Yihan Wang, Regine Bohacek, et al.
Bioorganic & Medicinal Chemistry Letters|August 28, 2003
Bone-targeted pyrido[2,3-d]pyrimidin-7-ones: potent inhibitors of Src tyrosine kinase as novel antiresorptive agentsChi B Vu, George P Luke, Noriyuki Kawahata, et al.
The Australasian Journal of Dermatology|March 3, 2017
Consensus statement for the treatment of infantile haemangiomas with propranololSarah L Smithson, Marius Rademaker, Susan Adams, et al.
Pageof 10